These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1970732)

  • 1. Inhibition of tyrosine-3-monooxygenase by benserazide.
    Reinhard JF; Shearin MD
    Biochem Pharmacol; 1990 May; 39(9):1489-91. PubMed ID: 1970732
    [No Abstract]   [Full Text] [Related]  

  • 2. Microdialysis monitoring of 3,4-dihydroxyphenylalanine accumulation after decarboxylase inhibition: a means to estimate in vivo changes in tyrosine hydroxylase activity of the rat locus ceruleus.
    Robert F; Lambás-Señas L; Ortemann C; Pujol JF; Renaud B
    J Neurochem; 1993 Feb; 60(2):721-9. PubMed ID: 8093483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preserved striatal tyrosine hydroxylase activity, assessed in vivo, following neonatal hypoxia-ischemia.
    Burke RE; Reches A
    Brain Res Dev Brain Res; 1991 Aug; 61(2):277-80. PubMed ID: 1684313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of a minor pathway of L-dopa metabolism in the intestinal lumen using a decarboxylase inhibitor (Ro 4-4602).
    Bakke OM; Scheline RR
    J Pharm Pharmacol; 1974 May; 26(5):377-9. PubMed ID: 4152920
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of l-DOPA and benserazide on the amount of dopamine in the corpus striatum of X-irradiated rats.
    Stepanović SR; Nikolić J
    Experientia; 1983 Sep; 39(9):1050-1. PubMed ID: 6411487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.
    Minsker DH; Stokes AL
    Experientia; 1974 Sep; 30(9):1051-3. PubMed ID: 4412113
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of some decarboxylase inhibitors on striatal tyramines in the mouse.
    Juorio AV
    Neuropharmacology; 1983 Jan; 22(1):71-3. PubMed ID: 6843786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The action L-dopa on sexual behaviour of male rats.
    Da Prada M; Carruba M; Saner A; O'Brien A; Pletscher A
    Brain Res; 1973 Jun; 55(2):383-9. PubMed ID: 4541349
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
    Yoshimine N; Kuzuya F; Mori K; Sakamoto N
    Nihon Ronen Igakkai Zasshi; 1978 Nov; 15(6):566-73. PubMed ID: 732010
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic and in vitro effects of GAD and GABA-T inhibitors on AADC activity and of AADC inhibitors on GAD.
    Giorgi O; Rubio MC
    Gen Pharmacol; 1981; 12(4):217-23. PubMed ID: 7250670
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential effect of benserazide on catecholamine concentrations in the rat pineal, cerebral cortex and hypothalamus.
    Ho AK; Smith JA
    Biochem Pharmacol; 1983 Dec; 32(23):3605-9. PubMed ID: 6651878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripherally administered (6R)-tetrahydrobiopterin increases in vivo tyrosine hydroxylase activity in the striatum measured by microdialysis both in normal mice and in transgenic mice carrying human tyrosine hydroxylase.
    Nagatsu T; Nakahara D; Kobayashi K; Morita S; Sawada H; Mizuguchi T; Kiuchi K
    Neurosci Lett; 1994 Nov; 182(1):44-6. PubMed ID: 7891884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of benserazide on the levels of pineal 5-hydroxytryptamine, melatonin synthesising enzymes and serum melatonin.
    Ho AK; Smith JA
    Biochem Pharmacol; 1982 Jul; 31(13):2251-5. PubMed ID: 6889864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gamma-hydroxybutyric acid, baclofen, aminooxyacetic acid, and apomorphine on dopamine turnover in corpus striatum and limbic system.
    Andén NE
    Adv Biochem Psychopharmacol; 1977; 16():495-9. PubMed ID: 18898
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of anaesthetic agents on the synthesis and disappearance of brain dopamine normally and after haloperidol, Kcl or axotomy.
    Andén NE; Magnusson T; Stock G
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(4):409-18. PubMed ID: 4153647
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of a decarboxylase inhibitor on the Dopa and 5-HTP induced changes in the locomotor-like discharge pattern of rabbit hind limb nerves.
    Viala D; Buser P
    Psychopharmacologia; 1974; 40(3):225-33. PubMed ID: 4548539
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in neostriatal DA metabolism after carbachol or atropine microinjections into the substantia nigra.
    Javoy F; Agid Y; Bouvet D; Glowinski J
    Brain Res; 1974 Mar; 68(2):253-60. PubMed ID: 4826898
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.
    Carlsson A; Davis JN; Kehr W; Lindqvist M; Atack CV
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(2):153-68. PubMed ID: 4404948
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of L-dopa and an inhibitor of peripheral decarboxylation on glucose metabolism in brain.
    Tyce GM
    J Neurochem; 1976 Dec; 27(6):1397-403. PubMed ID: 1003214
    [No Abstract]   [Full Text] [Related]  

  • 20. Skeletal changes induced by dopa decarboxylase inhibitor in rats.
    Tanaka C; Tanaka S; Itokawa Y; Takaori S
    Jpn J Pharmacol; 1973 Feb; 23(1):123-5. PubMed ID: 4541614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.